Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
Anupriya Aggarwal, Alberto Ospina Stella, Gregory J. Walker, et al.
Nature Microbiology (2022) Vol. 7, Iss. 6, pp. 896-908
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 937
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, et al.
EBioMedicine (2022) Vol. 84, pp. 104270-104270
Open Access | Times Cited: 138
Immunomodulatory Role of Interferons in Viral and Bacterial Infections
Paulina Mertowska, Konrad Smolak, Sebastian Mertowski, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10115-10115
Open Access | Times Cited: 48
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean, et al.
EBioMedicine (2023) Vol. 90, pp. 104545-104545
Open Access | Times Cited: 44
Recent advances in point-of-care testing of COVID-19
Sungwoon Lee, Liyan Bi, Hao Chen, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 24, pp. 8500-8530
Closed Access | Times Cited: 36
Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection
Chansavath Phetsouphanh, Brendan Jacka, Sara Ballouz, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination
Samuel M. S. Cheng, Chris Ka Pun Mok, John K.C. Li, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion
Yandong Shen, Jane A. Freeman, Juliette Holland, et al.
Blood (2022) Vol. 140, Iss. 25, pp. 2709-2721
Open Access | Times Cited: 29
Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2
Ellen Bowden-Reid, Scott Ledger, Yuan Zhang, et al.
Antiviral Research (2023) Vol. 217, pp. 105677-105677
Open Access | Times Cited: 14
Emerging anti-spike monoclonal antibodies against SARS-CoV-2
Eloy E. Ordaya, Raymund R. Razonable
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 3, pp. 191-201
Closed Access | Times Cited: 4
Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding
Gemma E. Hartley, Holly A. Fryer, Paul A. Gill, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Systematic Review of the Efficacy and Safety of RSV‐Specific Monoclonal Antibodies and Antivirals in Development
Andrea Sevendal, Siobhan Hurley, Adam Bartlett, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 5
Open Access | Times Cited: 3
Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti‐spike neutralizing IgG to SARS‐CoV‐2 variants, but preserved antigen‐specific T cell responses
Brendan Beaton, Sarah C. Sasson, Katherine Rankin, et al.
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 131-139
Open Access | Times Cited: 15
SKI-1/S1P Facilitates SARS-CoV-2 Spike Induced Cell-to-Cell Fusion via Activation of SREBP-2 and Metalloproteases, Whereas PCSK9 Enhances the Degradation of ACE2
Rachid Essalmani, Ursula Andréo, Alexandra Evagelidis, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 360-360
Open Access | Times Cited: 8
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variants
Lok Bahadur Shrestha, Katie Tungatt, Anupriya Aggarwal, et al.
EBioMedicine (2024) Vol. 110, pp. 105461-105461
Open Access | Times Cited: 2
TMPRSS2 activation of Omicron lineage Spike glycoprotein is regulated by Collectrin-like domain of ACE2
Anupriya Aggarwal, Christina Fichter, Vanessa Milogiannakis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Real‐world experience of tixagevimab‐cilgavimab pre‐exposure prophylaxis in orthotopic heart transplant recipients
Eloy E. Ordaya, Eibhlin Higgins, Paschalis Vergidis, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. 3
Closed Access | Times Cited: 6
SARS-CoV-2 variants, its recombinants and epigenomic exploitation of host defenses
Nitin K. Saksena, Srinivasa Bonam Reddy, Monica Miranda‐Saksena, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 8, pp. 166836-166836
Open Access | Times Cited: 6
High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells
Chansavath Phetsouphanh, Weng Hua Khoo, Katherine Jackson, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Emerging alternatives to traditional anthelmintics: the in vitro antiparasitic activity of silver and selenium nanoparticles, and pomegranate (Punica granatum) peel extract against Haemonchus contortus
Ahmed M. Kaiaty, Fayez A. Salib, Sohila M. El-Gameel, et al.
Tropical Animal Health and Production (2023) Vol. 55, Iss. 5
Open Access | Times Cited: 5
Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?
István Vályi‐Nagy, Ferenc Uher, Éva Rákóczi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13951-13951
Open Access | Times Cited: 9
Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages
Jean‐Sélim Driouich, Maxime Cochin, Guillaume Lingas, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116988-116988
Open Access | Times Cited: 1
Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer
Amy Body, Luxi Lal, Sriganesh Srihari, et al.
Vaccine (2024), pp. 126547-126547
Open Access | Times Cited: 1
Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core
Pantelis Poumbourios, Christine Langer, Irene Boo, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 5, pp. e1010981-e1010981
Open Access | Times Cited: 3
Visual evoked potentials waveform analysis to measure intracortical damage in a preclinical model of multiple sclerosis
Silvia Marenna, Elena Rossi, Su‐Chun Huang, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top